by EmVenio | Oct 21, 2024 | Blog
At EmVenio, we believe community intervention is the first step to creating inclusivity and trust in clinical research. This month, we had the privilege of meeting community members of the Greater Atlanta area at “Reflections Atlanta: Illuminating Diversity in...
by Katy Keating | Oct 17, 2024 | Blog
EmVenio has been an active member in the Society of Clinical Research Sites since our founding in 2022, and many of our team members have been involved in the SCRS community over the course of their careers. We also recently joined SCRS’s Global Impact Partner...
by Katy Keating | Oct 16, 2024 | Blog
EmVenio leadership and staff gathered in late September for a ribbon-cutting and open house at one of our first clinical trial research centers within the Prime Healthcare hospital system. This location is inside the Southern Regional Medical Center in Riverdale,...
by EmVenio | Aug 14, 2024 | Blog
The United States Food and Drug Administration has issued several guidances throughout the last five years to enhance the diversity, equity, and inclusivity of clinical trials. These are significant and much-needed additions to the industry, supporting EmVenio’s...
by EmVenio | Jun 6, 2024 | Blog
June 6th, 2024 – The Society for Clinical Research Sites (SCRS) proudly announces the addition of EmVenio Research to its Global Impact Partner (GIP) Program. EmVenio, a PCM Trials company, is part of the largest independent decentralized clinical trial (DCT) site...
by EmVenio | May 31, 2024 | Blog
Our collaboration with local organizations creates opportunity to address critical health issues and topics through the lens of clinical research, promoting wellness, and bringing value to the communities we serve. The well-being of our communities remains at the...
